Search for: "Teva Pharmaceuticals" Results 1261 - 1280 of 1,436
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Jan 2019, 4:14 am by Edith Roberts
Teva Pharmaceuticals, in which the court held that an invention is “on sale,” and therefore cannot be patented, if the inventor made a “secret sale” of the invention before seeking a patent. [read post]
11 Mar 2015, 9:40 am by Dennis Crouch
Akamai Technologies, Inc., 134 S.Ct. 2111 (2014) (divided infringement) Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
10 Jun 2013, 8:20 pm by Lyle Denniston
  The one-pill version is made by Teva Pharmaceutical Products. [read post]
20 Nov 2008, 8:29 pm
  Note that financial support for this white paper was provided by Teva Pharmaceuticals. [read post]
Teva Pharmaceuticals USA, Inc., 731 F.3d  918 (9th Cir. 2013), attorneys for many plaintiffs in 40 product liability actions filed in California state courts asked California judicial council to invoke a state rule of procedure allowing coordination of common actions for all purposes. [read post]
Although the Court of Appeal was clear, in Neurim v Generics [2020] EWCA Civ 793, that deciding to uphold the lower court’s decision not to grant a pharmaceutical patent PI was based on the specific facts of that case, the Patents Court has subsequently refused two further pharmaceutical PIs (Neurim v Teva [2022] EWHC 954 (Pat) and [2022] EWHC 1641(Pat), and Novartis v Teva [2022] EWHC 959 (Ch)). [read post]
5 Jan 2023, 2:22 pm by Kevin LaCroix
  Teva Pharmaceutical The $420 million settlement between Teva and investors resolves allegations that the company engaged in a generic drug price-fixing conspiracy that allowed it to drastically raise prices on generic drugs from 2013 to 2015 – as high as 1,000%. [read post]
2 Aug 2008, 12:54 am
, (Daily Dose of IP), 20 August – Bill Patry Copyright Blog speaking on copyright – Melbourne: (Patry Copyright Blog), (LawFont.com), 21 August – Bill Patry Copyright Blog speaking on copyright – Canberra: (Patry Copyright Blog), (LawFont.com), 22 August – Bill Patry Copyright Blog speaking on copyright – Sydney: (Patry Copyright Blog), (LawFont.com), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat),… [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
11 Jan 2008, 9:00 am
: (Biotech Weblog),Immunomedics obtains antibody patent: (SmartBrief),Cyplasin Biomedical obtains US patent for protein based cancer treatment: (Patent Docs)Argatroban - Encysive Pharmaceuticals Inc., GlaxoSmithKline and Mitsubishi Chemical Corp. file patent infringement lawsuit to stop Barr Laboratories from producing a generic version of the anti-blood clotting drug: (IP Law360), Biaxin (Clarithromycin) - Court holds in Abbott Labs v Sandoz… [read post]
27 Oct 2014, 5:27 am
 * Obviousness, common general knowledge and expectations of success: Leo gets a mauling Jeremy hosts this post by Suleman Ali (Holly IP) on Teva UK Limited & Teva Pharmaceuticals Limited v Leo Pharma A/S & Leo Laboratories Limited [2014] EWHC 3096 (Pat), a decision by Mr Justice Birss in the Patents Court, England and Wales which addresses two patent law cornerstones: obviousness and common general knowledge. [read post]
23 Oct 2009, 4:12 pm
Teva Pharmaceuticals USA, Inc. and related cases) (2009 U.S. [read post]
30 Jul 2021, 7:01 am by Simmons Hanly Conroy
., Teva Pharmaceutical Industries Ltd., and AbbVie Inc’s Allergan unit, which all stand accused of having deceptively marketed their opioid painkillers. [read post]
3 Aug 2011, 3:31 am by Marie Louise
: Cour d’Appel Paris decision in Teva v Eli Lilly (Kluwer Patent Blog) US: CAFC confirms that isolated DNA may be patented: Association for Molecular Pathology v. [read post]
2 Sep 2016, 1:57 pm by John Stigi
  There, plaintiffs brought a putative class action complaint challenging the sale of Auspex Pharmaceuticals, Inc. to Teva Pharmaceuticals Industries, Inc. [read post]
28 Sep 2015, 9:07 am by Jason Rantanen
Teva Pharmaceuticals USA, Inc., 549 Fed. [read post]